GR920100519A - Compounds. - Google Patents

Compounds.

Info

Publication number
GR920100519A
GR920100519A GR920100519A GR920100519A GR920100519A GR 920100519 A GR920100519 A GR 920100519A GR 920100519 A GR920100519 A GR 920100519A GR 920100519 A GR920100519 A GR 920100519A GR 920100519 A GR920100519 A GR 920100519A
Authority
GR
Greece
Prior art keywords
compounds
interrupt
tnf
production
hylidene
Prior art date
Application number
GR920100519A
Other languages
Greek (el)
Inventor
Jutta Forster Cornellia
Elliot Bender Paul
Benjamin Christensen Siegfried
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of GR920100519A publication Critical patent/GR920100519A/en

Links

Abstract

New cyclohexano-hylidene derivatives are described which interrupt Tumour Necrosis Factor (TNF) production and are useful in treatment of disease conditions caused or aggravated by TNF production. The compounds of this patent can also be used to inhibit or interrupt the enzymatic or catalytic action of phosphodiesterase IV.
GR920100519A 1992-11-26 1992-11-26 Compounds. GR920100519A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR92100519 1992-11-26

Publications (1)

Publication Number Publication Date
GR920100519A true GR920100519A (en) 1994-07-29

Family

ID=10941240

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100519A GR920100519A (en) 1992-11-26 1992-11-26 Compounds.

Country Status (1)

Country Link
GR (1) GR920100519A (en)

Similar Documents

Publication Publication Date Title
GB9323165D0 (en) Compounds
HK1012262A1 (en) Compounds useful for treating allergic or inflammatory diseases
TW225532B (en)
ES8704206A1 (en) Vectors and methods for expression of human protein C activity.
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
CA2133439A1 (en) Compounds useful for treating allergic and inflammatory diseases
MY121294A (en) Novel hexanoic acid derivatives.
WO1993019720A3 (en) Compounds
PL340551A1 (en) Derivatives of hydroxamic and carboxylic acids exhibiting mmp & tnf inhibitive action
AU558711B2 (en) Enzyme preparation for treatment of liver and kidney disease
GR3033034T3 (en) Novel pyrazine carboxamide derivatives, their production and their use in medicaments
ES2000734A6 (en) Hydroxy and alkoxy pyrimidines.
DE3662041D1 (en) New carboxylic acid derivatives, their manufacturing process, use and medicines containing these compounds
ZA889699B (en) Use of polysulfated heparins
GB2099008B (en) Enzymatic process for the treatment of xanthan gums to improve the filtrability of their aqueous solutions
GR920100519A (en) Compounds.
GR920100521A (en) Compounds.
GR920100518A (en) Compounds.
KR100344711B1 (en)
GR920100520A (en) Compounds.
HUP9802142A2 (en) Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
IE56456B1 (en) Arthritis treatment
ES2148057A1 (en) Enhancement of PDE 3 inhibitors effect consists of using diacepam as a general aid to pharmaceuticals